These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10063967

  • 1. FHITness and cancer.
    Druck T, Berk L, Huebner K.
    Oncol Res; 1998; 10(7):341-5. PubMed ID: 10063967
    [Abstract] [Full Text] [Related]

  • 2. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.
    Cancer Res; 1997 Nov 01; 57(21):4692-8. PubMed ID: 9354423
    [Abstract] [Full Text] [Related]

  • 3. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 4. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S.
    Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304
    [Abstract] [Full Text] [Related]

  • 5. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA, Barski P, Batley SJ, Li L, de Foy KA, Cohen SN, Ponder BA, Caldas C.
    Oncogene; 1997 Oct 23; 15(17):2119-26. PubMed ID: 9366528
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
    Genes Chromosomes Cancer; 1997 Sep 23; 20(1):98-102. PubMed ID: 9290961
    [Abstract] [Full Text] [Related]

  • 7. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A, Srinivasan R, Shabnam MS, Majumdar S, Joshi K, Behera D.
    Mol Cancer Res; 2006 Feb 23; 4(2):93-9. PubMed ID: 16513840
    [Abstract] [Full Text] [Related]

  • 8. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S, Neilly ME, Espinosa R, Davis EM, McKeithan TW, Le Beau MM.
    Cancer Res; 2002 Jun 15; 62(12):3477-84. PubMed ID: 12067991
    [Abstract] [Full Text] [Related]

  • 9. Loss of FHIT expression in gastric carcinoma.
    Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K.
    Cancer Res; 1998 Oct 15; 58(20):4708-14. PubMed ID: 9788626
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID, Szeles A, Yang Y, Klein G, Imreh S.
    Cancer Res; 2000 Dec 15; 60(24):7119-25. PubMed ID: 11156420
    [Abstract] [Full Text] [Related]

  • 11. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
    Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K, Lubinski J.
    Cancer Res; 1998 Jul 15; 58(14):2946-51. PubMed ID: 9679951
    [Abstract] [Full Text] [Related]

  • 12. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC.
    Cancer Res; 2000 Feb 15; 60(4):1049-53. PubMed ID: 10706123
    [Abstract] [Full Text] [Related]

  • 13. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B.
    Cancer Res; 2000 Jun 01; 60(11):2780-5. PubMed ID: 10850413
    [Abstract] [Full Text] [Related]

  • 14. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.
    Lott ST, Lovell M, Naylor SL, Killary AM.
    Cancer Res; 1998 Aug 15; 58(16):3533-7. PubMed ID: 9721855
    [Abstract] [Full Text] [Related]

  • 15. Fragile histidine triad gene and skin cancer.
    Zanesi N, Croce CM.
    Eur J Dermatol; 2001 Aug 15; 11(5):401-4. PubMed ID: 11525944
    [Abstract] [Full Text] [Related]

  • 16. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
    Yu HG, Shun LB, Luo HS, Huang H, Yu BP, Yu JP, Meier JJ, Schrader H, Bastian A, Schmitz F, Schmidt WE.
    Int J Colorectal Dis; 2002 Nov 15; 17(6):396-401. PubMed ID: 12355215
    [Abstract] [Full Text] [Related]

  • 17. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA.
    Cancer Res; 1999 Jul 15; 59(14):3333-9. PubMed ID: 10416589
    [Abstract] [Full Text] [Related]

  • 18. Structure and expression of the human FHIT gene in normal and tumor cells.
    Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K.
    Cancer Res; 1997 Feb 01; 57(3):504-12. PubMed ID: 9012482
    [Abstract] [Full Text] [Related]

  • 19. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
    Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, Dagenais SL, Wilke CM, Dierick HA, Beer DG.
    Cancer Res; 1998 Aug 01; 58(15):3409-14. PubMed ID: 9699673
    [Abstract] [Full Text] [Related]

  • 20. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H, Vecchione A, Furukawa Y, Sutheesophon K, Han SY, Druck T, Kuroki T, Trapasso F, Nishimura M, Saito Y, Ozawa K, Croce CM, Huebner K, Furukawa Y.
    Mol Cancer Res; 2003 Nov 01; 1(13):940-7. PubMed ID: 14638866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.